Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;34(1):306-311.
doi: 10.1038/s41375-019-0546-1. Epub 2019 Aug 21.

Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing

Affiliations

Cryptic genomic lesions in adverse-risk acute myeloid leukemia identified by integrated whole genome and transcriptome sequencing

Jaeseung C Kim et al. Leukemia. 2020 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Cryptic NUP98-KDM5A and NUP98-BPTF fusion events in case 4 (left panels) and case 6 (right panels), respectively. a, e Partial karyograms of chromosomes 11, 12, and 17 and relevant cytogenetic findings. b, f Schematic representations of SVs in aforementioned chromosomes. Rearranged chromosomes, predicted from SVs and cytogenetics, are shown below. Arrows represent genes in 5′ to 3′ direction, alphabets represent genomic segments demarcated by case-specific breakpoints, apostrophes represent inverted segments, dashed lines represent SVs, and red dashed lines represent SVs leading to gene fusions. c, g Reverse transcription (RT)-PCR and Sanger sequencing of fusion transcripts. Arrows represent fused exons in 5′ to 3′ direction and letters below nucleotide codons represent corresponding amino acids. d, h Predicted fusion proteins and their domain structures adapted from UniProt. Arrows represent fused proteins and numbers represent amino acid positions

References

    1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405. doi: 10.1182/blood-2016-03-643544. - DOI - PubMed
    1. Speicher MR, Carter NP. The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet. 2005;6:782–92. doi: 10.1038/nrg1692. - DOI - PubMed
    1. Haferlach C, Dicker F, Herholz H, Schnittger S, Kern W, Haferlach T. Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype. Leukemia. 2008;22:1539–41. doi: 10.1038/leu.2008.143. - DOI - PubMed
    1. Welch JS, Westervelt P, Ding L, Larson DE, Klco JM, Kulkarni S, et al. Use of whole-genome sequencing to diagnose a cryptic fusion oncogene. J Am Med Assoc. 2011;305:1577–84. doi: 10.1001/jama.2011.497. - DOI - PMC - PubMed
    1. King RL, Naghashpour M, Watt CD, Morrissette JJD, Bagg A. A comparative analysis of molecular genetic and conventional cytogenetic detection of diagnostically important translocations in more than 400 cases of acute leukemia, highlighting the frequency of false-negative conventional cytogenetics. Am J Clin Pathol. 2011;135:921–8. doi: 10.1309/AJCPJCW6BY0CNIHD. - DOI - PubMed

Publication types

Grants and funding